Soleno Therapeutics Inc
SLNODelisted May 18, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001484565
Soleno Therapeutics Inc was delisted on May 18, 2026; its insiders filed their last Form 4 on May 18, 2026; 227 institutions reported holding it in 13F filings for Q1 2026, worth $2.09B in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Soleno Therapeutics Inc changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 47 | 39 | −8 |
| Shares | 29.6M | 29.4M | −213.7K (−0.7%) |
| Value | $33.6M | $27.1M | −$6.49M (−19.3%) |
New holders (5)
Institutions that held Soleno Therapeutics Inc at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Granite Point Capital Management, L.P. | 701,838 | $649.0K | 0.25% |
| Migdal Insurance & Financial Holdings Ltd. | 17,524 | $16.0K | 0.00% |
| Aspiriant, LLC | 17,295 | $16.0K | 0.00% |
| PEAK6 Investments LLC | 12,388 | $11.0K | 0.00% |
| Bray Capital Advisors | 2,000 | $2.00K | 0.00% |
Sold out (13)
Institutions that held Soleno Therapeutics Inc at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| SG Americas Securities, LLC | 299,074 | $341.0K |
| Tibra Equities Europe Ltd | 298,700 | $341.0K |
| Millennium Management LLC | 194,965 | $222.0K |
| Goldman Sachs Group Inc | 109,382 | $124.0K |
| XTX Topco Ltd | 24,975 | $28.0K |
| Two Sigma Securities, LLC | 19,219 | $22.0K |
| LMR Partners LLP | 19,500 | $22.0K |
| Tower Research Capital LLC (TRC) | 18,388 | $21.0K |
| Winton Group Ltd | 14,361 | $16.0K |
| Y-Intercept (Hong Kong) Ltd | 13,574 | $15.0K |
| ExodusPoint Capital Management, LP | 11,011 | $13.0K |
| Bank of America Corp | 6,996 | $8.00K |
| New York State Common Retirement Fund | 528 | $1.00K |